SCHEMBL27712571

SCHEMBL27712571

O=C(CCl)Nc1ccc(C(F)(F)F)c(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTO1 P78417 5/20 0.60
▸ KDR P35968 2/20 0.54
▸ KCNJ5 P48544 1/20 0.52
▸ KCNJ3 P48549 1/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ HTT P42858 3/20 0.51
▸ LMNA P02545 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ NPY1R P25929 1/20 0.51
▸ NPY2R P49146 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ HIF1A Q16665 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4443052 0.88 KDR (0.71) GSTO1KDRKCNJ5KCNJ3SMN1; SMN2
SCHEMBL9728728 0.88 KDR (0.54) GSTO1KDRKCNJ5KCNJ3SMN1; SMN2
SCHEMBL4556067 0.83 KDR (0.75) KDRSMN1; SMN2HTTLMNAMEN1
SCHEMBL5248618 0.82 KDR (0.58) KDRKCNJ5KCNJ3SMN1; SMN2HTT
SCHEMBL11787916 0.82 KDR (0.58) KDRKCNJ5KCNJ3SMN1; SMN2HTT
SCHEMBL4006280 0.81 GRM4 (0.57) GSTO1KDRKCNJ5KCNJ3SMN1; SMN2
SCHEMBL28875490 0.81 KDR (0.57) KDRSMN1; SMN2MAPTMEN1KMT2A
SCHEMBL5742985 0.81 KDR (0.57) KDRSMN1; SMN2HTTLMNAMAPT
Fluoride SCHEMBL11787921 0.81 KDR (0.57) KDRKCNJ5KCNJ3HTTMEN1
SCHEMBL28882268 0.80 GSTO1 (0.59) GSTO1KDRKCNJ5KCNJ3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128427-B Heterocyclic compounds as ccr2b antagonists ASTRAZENECA AB 2013-03-27 — — CN disclosed
CN-101128427-A Heterocyclic compounds as ccr2b antagonists ASTRAZENECA AB (SE) 2008-02-20 — — CN disclosed
Send feedback